AGF Management Ltd. Buys 4,819 Shares of HealthEquity, Inc. (NASDAQ:HQY)

AGF Management Ltd. raised its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 135,857 shares of the company’s stock after purchasing an additional 4,819 shares during the period. AGF Management Ltd.’s holdings in HealthEquity were worth $13,035,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Arcadia Investment Management Corp MI acquired a new position in HealthEquity during the 4th quarter valued at about $26,000. Smartleaf Asset Management LLC boosted its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of HealthEquity in the 4th quarter worth approximately $39,000. UMB Bank n.a. boosted its stake in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the last quarter. Finally, Lindbrook Capital LLC boosted its stake in shares of HealthEquity by 27.6% in the 4th quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock worth $72,000 after buying an additional 162 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Up 1.3 %

Shares of NASDAQ:HQY opened at $95.74 on Wednesday. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The firm has a fifty day moving average of $105.75 and a 200 day moving average of $94.80. The firm has a market capitalization of $8.30 billion, a PE ratio of 87.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the firm earned $0.40 EPS. As a group, research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the sale, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. JMP Securities lifted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Wells Fargo & Company lifted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Mizuho began coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Finally, Raymond James boosted their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Tuesday, February 25th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and an average target price of $113.54.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.